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Rat pancreatic islet homogenates display protein kinase C activity. This phospholipid-dependent and 
calcium-sensitive enzyme is activated by diacylglycerol or the tumor-promoting phorbol ester 12-G 
tetradecanoylphorbol-13-acetate (TPA). In the presence of TPA, the Ka for Ca’+ is close to 5 FM. TPA 
does not affect phosphoinositide turnover but stimulates [32P]- and [‘HIcholine-labelling of 
phosphatidylcholine in intact islets. Exogenous phospholipase C stimulates insulin release, in a sustained 
and glucose-independent fashion. The secretory response to phospholipase C persists in media deprived 
of CaC12. It is proposed that protein kinase C participates in the coupling of stimulus recognition to insulin 
release evoked by TPA, phospholipase C and, possibly, those secretatogues causing phosphoinositide 
breakdown in pancreatic islets. 
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1. INTRODUCTION 2.1. Assay of protein kinase 
In the pancreatic B-cell, protein kinases are 
thought to play an important role in the coupling 
of stimulus recognition to insulin release. Three 
types of protein kinases have already been iden- 
tified in pancreatic islet cells, namely the cyclic 
AMP-responsive protein kinase A [l-3], a Ca- 
calmodulin-sensitive kinase [4-B] and the phos- 
pholipid-dependent Ca’+-responsive protein 
kinase C which is activated by unsaturated iacyl- 
glycerol [9]. This work deals with both the activa- 
tion of the latter enzyme by the tumor-promoting 
agent 12-O-tetradecanoylphorbol-13-acetate 
(TPA) and the possible participation of protein 
kinase C in stimulus-secretion coupling. 
For the assay of protein kinase C, batches of 
500-1000 islets were sonicated (3 times 5 s) in a 
Tris-HCl buffer (50 mM; pH 7.5) containing 
EGTA (0.2 mM), MgCl2 (10 mM), 2-mercapto- 
ethanol (50 mM) and Triton X-100 (0. I%, v/v), in 
a ratio of about 500 islets per ml. Aliquots (50~1) 
of this crude homogenate were added to 150 ~1 of 
a reaction mixture to yield the following final con- 
centrations: Tris-HCI (50 mM; pH 7.5), EGTA 
(0.2 mM), MgClz (10 mM), 2-mercaptoethanol 
(12.5 mM), Triton X-100 (0.025%, v/v), lysine- 
rich histone from calf thymus (0.2 mg/ml; type 
III-S, Sigma, St. Louis, MO), ATP (0.1 mM; 
sodium salt) mixed with a tracer amount of 
[Y-‘~P]ATP (6 &i/ml; Amersham International, 
Buckinghamshire) and, as required, L-cY-phos- 
phatidyl-L-serine (25 pug/ml) emulsified by sonica- 
tion in a Tris-HCl buffer (see above) containing 
bovine albumin (0.1 mg/ml), 1,3-diolein (1 pg/ml 
or 1.6 PM; solubilized in DMSO at an initial con- 
centration of 10 mg/ml; Sigma), TPA (20 nM; PL 
Biochemicals, Milwaukee, WI) and/or the com- 
2. MATERIALS AND METHODS 
All experiments were performed with isolated 
islets removed from the pancreas of fed albino rats 
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bination of cyclic AMP (10pM) and theophylline 
(2.5 mM). The Ca2+ concentration of the reaction 
mixture was adjusted by addition of CaClz 
(0.2-0.7 mM). After 2 min preincubation, the 
reaction was initiated by the addition of ATP and, 
after 5 min incubation at 30°C terminated by the 
rapid and successive addition of a solution (200 ~1) 
of bovine albumin (10 mg/ml) in Tris-HCl buffer 
(see above) and 1 .O ml trichloroacetic acid (10070, 
w/v). After centrifugation, the precipitate was 
redissolved in 1.0 ml NaOH (0.5 M) and TCA 
(1 .O ml) was again added. After 5 such successive 
washes, the final precipitate was redissolved in 
NaOH and examined for its radioactive content by 
liquid scintillation. Blank values were measured in 
the absence of islet homogenate. 
The assay of protein kinase A was performed in 
a similar manner. The islets were sonicated in the 
same Tris-HCl buffer (about 750 islets/ml) con- 
taining EGTA (0.2 mM) and MgCl2 (10 mM) but 
neither mercaptoethanol nor Triton X-100. The 
type of histones (type IIA; Sigma) and their final 
concentration (2.5 mg/ml) were also different 
from those used in the assay of protein kinase C. 
In the assay of either protein kinase C or A, the 
incorporation of 32 P into trichloroacetic acid- 
precipitable material was related to the amount of 
tissue (r = 0.906, n = 7). The reaction velocity was 
not linear with time, a situation possibly at- 
tributable to interference of protein phosphatase. 
The time of incubation was restricted, therefore, to 
either 5 (protein kinase C) or 10 min (protein 
kinase A). All determinations were made in 
triplicate, and the results expressed relative to the 
mean basal value found within the same 
experiment. 
2.2. Phospholipid metabolism 
Islet phospholipids were labelled by preincuba- 
tion with either 32Pi (carrier-free), myo-[2-3H]in- 
ositol (16.6 Ci/mmol), [1(3)-3H]glycerol (3 Ci/ 
mmol) or [methyl-3H]choline chloride (60 Ci/ 
mmol). The radioactivity of the preincubation me- 
dium ranged from 5-lOO&i/ml. The methods 
used for separation of islet phospholipids and their 
metabolites are described in detail in [ 11,121. 
2.3. Insulin release 
Insulin release from intact islets was measured as 
in [ 131. Two preparations of phospholipase C ex- 
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tracted from Clostridium perfringens (Sigma) and 
Bacillus cereus (Boehringer, Mannheim), respec- 
tively, were used. 
2.4. Presentation of results 
All results are expressed as the mean (f SE) 
together with the number of individual determina- 
tions (n). The statistical significance of differences 
between mean values was assessed by the use of 
Student’s t-test. 
3. RESULTS 
3.1. Protein kinase activity in islet homogenates 
In a first series of experiments, lysine-rich 
histones were used as the substrate for protein 
kinase C. The islet homogenates catalyzed the in- 
corporation of 32P from [Y-~~P]ATP into such 
histones. The reaction velocity failed to be 
significantly affected by the presence of Ca2+ 
and/or the combination of cyclic AMP and 
theophylline (table 1, lines l-4). In the absence of 
Ca2+, diolein or TPA also failed to affect 
significantly the incorporation of 32P in the histone 
(table 1, lines 7,9). In the absence of Ca’+, the 
presence of phosphatidylserine tended to slightly 
increase the incorporation of 32P into 
trichloroacetic acid-precipitable material (table 1, 
lines 5,11,13,16), but failed to confer any 
Ca’+-sensitivity to the assay system (table 1, lines 
5,6). In the absence of exogenous phospholipid but 
presence of diolein, Ca2+ tended to decrease 32P in- 
corporation into the trichloroacetic acid- 
precipitable material (table 1, lines 7,8). Inversely, 
TPA in the absence of exogenous phospholipid ap- 
parently conferred to the system a limited but 
significant (p < 0.001) and positive reactivity 
towards Ca2+ (table 1, lines 9,lO). In the presence 
of phosphatidylserine, diolein and, even more so, 
TPA caused obvious stimulation of enzyme activi- 
ty provided that Ca2+ was also present in the in- 
cubation medium (table 1, lines 11-14). Diolein 
failed to further enhance the response to TPA in 
media containing both phosphatidylserine and 
Ca2+ (table 1, lines 14,15). Likewise, cyclic AMP 
and theophylline failed to affect significantly the 
reaction velocity recorded in the combined 
presence of TPA, phosphatidylserine and Ca2+ 
(table 1, lines 14,17). In the presence of 
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Table 1 
Presence of protein kinase C activity in islet homogenates 
Line Phosphatidyl- 
serine 
(25 pg/ml) 
Diolein 
(1.6pM) 
TPA 
(20 nM) 
Cyclic AMPa Ca*+ Reaction velocityb 
(LO rM) (0.5 mM) (Q) 
1 _ - - - _ 100.0 * 4.8 (10) 
2 __ _ _ _ + 102.2 f 4.9 (7) 
3 - _ _ + - 101.4 f 4.8 (3) 
4 - - _ + + 100.6 * 5.7 (2) 
5 + _ - - - 119.8 + 4.8 (5) 
6 + - - - + 116.0 f 3.6 (4) 
7 _ + - - - 105.3 f 4.8 (4) 
8 _ + - - + 81.4 f 9.3 (4) 
9 - - + - - 105.2 f 3.3 (8) 
10 - _ + - + 133.6 f 4.3 (4) 
11 + + - - - 117.3 f 5.4 (4) 
12 + + - - + 156.5 f 3.7 (6) 
13 + - + - _ 116.1 + 6.9 (8) 
14 + _ + - + 200.5 + 9.3 (10) 
15 + + + - + 202.1 + 5.2 (3) 
16 + - + + _ 113.7 + 6.1 (4) 
17 + - + + + 213.8 f 9.7 (4) 
a Theophylline (2.5 mM) was always added to cyclic AMP 
b Mean values (it SE) for the reaction velocity are expressed in percentages of the paired basal value (first line) and 
shown together with the number of individual experiments (in parentheses), the basal value averaging 175 f 
12 fmol/5 min per islet 
phosphatidylserine and TPA, the reaction velocity 
at increasing concentrations of Ca2+ was compati- 
ble with a threshold concentration for activation 
by Ca2+ close to 0.04 PM and a K, close to 5 ,uM 
(fig. 1). 
In order to further assess the specificity of the 
response to TPA, the experiments were repeated in 
an assay system designed to measure the activity of 
protein kinase A. In this system, cyclic AMP and 
theophylline, if used in combination, markedly in- 
creased the reaction velocity (table 2, lines l-4). 
Such was not the case for the combination of 
phosphatidylserine, TPA and Ca2+ (table 2, line 
5). The presence of the latter combination did not 
prevent the activation of the cyclic AMP- 
Fig.1. Effect of increasing Ca*+ concentrations 
(logarithmic scale) upon the velocity of histone 
phosphorylation by islet homogenates in the presence of 
phosphatidylserine (25 /g/ml) and TPA (20 nM). The 
basal value averaged 0.21 f 0.02 pmol/5 min per islet. 
Mean values ( f SE) refer to 6 individual determinations. 
2.5- 
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Table 2 
Presence of cyclic AMP-dependent protein kinase in islet homogenates 
Line Phosphatidyl- 
serine 
(25 pg/ml) 
TPA 
(20 nM) 
2+ 
(O.?mM) 
Cyclic AMP Theophylline Reaction velocitya 
(10 PM) (2.5 mM) (To) 
1 - _ _ 100.0 f 5.4 (10) 
2 - - + - 106.2 f 2.8 ( 2) 
3 - - - + 108.4 f 1.8 ( 2) 
4 _ _ + + 162.5 + 5.3 (10) 
5 + + + - - 91.4 * 3.7 ( 3) 
6 + + + + + 146.0 + 9.4 ( 3) 
a Mean values ( f SE) for the reaction velocity are expressed in percentages of the mean basal value (first line) and shown 
together with the number of individual experiments (in parentheses), the basal value averaging 526 + 32 fmol/lO min 
per islet 
dependent kinase by the cyclic nucleotide and 
phosphodiesterase inhibitor (table 2, lines 5,6). 
3.2. TPA and the phosphatidylinositol cycle 
Two experimental approaches were used to 
detect a possible effect of TPA upon the turnover 
of inositol-containing phospholipids in the pan- 
creatic islets. In the first approach, groups of 140 
islets each were preincubated for 120 min in the 
presence of 2.8 mM D-glucose and a tracer 
amount of 32Pi and then further incubated for 
30 min at the same glucose and ‘*Pi concentration 
in the absence or presence of TPA (2.0 PM). As 
shown in table 3, TPA failed to affect the 32P- 
labelling of polyphosphoinositides, phosphatidyl- 
inositol, phosphatidic acid, phosphatidylethanol- 
amine and lysophosphatidylcholine. However, the 
radioactivity associated with phosphatidylcholine 
was increased by about 50% above basal value (p 
< 0.05). In the second approach, groups of 150 
islets each were preincubated for 180 min in the 
presence of 2.8 mM D-glucose and [3H]inositol. 
The medium was then removed and the islets fur- 
ther incubated for 30 min in fresh medium con- 
taining 2.8 mM D-glucose, 10 mM LiCl, 1.0 mM 
unlabelled inositol and, as required, TPA (0.2 or 
2.0rM). The phorbol ester failed to stimulate the 
production of [3H]inositol phosphates, which 
averaged 736 + 72, 633 + 21 and 822 + 
156 cpm/l50 islets (n = 3 in each case) in the 
absence and presence of 0.2 pM and 2.0 ,uM TPA, 
respectively. 
Table 3 
Effect of TPA upon the radioactivity of phospholipids (cpm/islet) in islets exposed to either 32Pi 
or [3H]glycerol 
TPA 
PPI 
PA 
PI 
PC 
LC 
PE 
“Pi labelling [3H]Glycerol labelling 
Nil 2.0 pM Nil 2.0 PM 
53.6 + 2.8a 51.9 f 1.4 14.5 * 0.7 13.4 * 0.4 
26.2 f 0.6 28.2 f 1.8 6.7 + 0.6 6.6 f 0.3 
126.9 + 4.7 129.2 f 8.6 33.2 f 2.4 31.7 + 1.7 
34.7 * 1.3 54.1 f 2.5 73.0 f 3.2 71.6 + 4.8 
15.2 f 2.9 16.9 + 3.8 7.4 * 1.1 6.7 + 1.7 
34.8 -f- 1.1 35.9 + 1.8 90.7 f 3.4 93.0 ztz 2.4 
a Mean values (+ SE) refer to 3 individual observations in each case. PPI, polyphosphoinositides; 
PA, phosphatidic acid; PI, phosphatidylinositol; PC, phosphatidylcholine; LC, 
lysophosphatidylcholine; PE, phosphatidylethanolamine 
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Table 4 
Effect of phospholipase C (10 munits/ml) upon insulin release 
Line D-Glu- Ca2+ Phospholipase C Insulin output @units/30 min per islet) P 
case (mM) (source) 
(mM) Control Test Increment 
1 1.0 C. perfringens 8.9 + 1.4 (17) 13.1 f 1.3 (18) +4.2 + 1.9 < 0.05 
2 3.3 1.0 C. perfringens 9.0 f 1.0 (34) 17.7 f 1.8 (36) +8.7 f 2.1 co.001 
3 3.3 1.0 B. cereus 9.7 f 1.5 (35) 34.6 + 3.4 (36) +24.9 f 3.7 <O.OOl 
4 3.3 - B. cereus 11.4 f 3.3 (18) 33.2 f 2.1 (18) +21.7 f 3.9 < 0.001 
5 8.3 1.0 B. cereus 49.0 + 2.4 (18) 74.1 * 2.8 (18) +25.0 f 3.7 <O.OOl 
6 16.7 1.0 B. cereus 113.9 f 5.3 (18) 131.2 f 5.7 (18) + 17.3 f 7.7 <0.05 
The finding that TPA increased the 32P-labelling 
of phosphatidylcholine led us to perform two fur- 
ther series of experiments. In the first series, 
groups of 215 islets each were preincubated for 
180 min in the presence of 2.8 mM D-glucose and 
a tracer amount of [‘HIglycerol, and then further 
incubated for 15 min at the same glucose and 
[3H]glycerol concentrations in the absence or 
presence of TPA (2.0pM). The phorbol ester 
failed to affect significantly the 3H-labelling of 
islet phospholipids, including phosphatidylcholine 
and lysophosphatidylcholine (table 3). In the 
second series of experiments, groups of 60 islets 
each were preincubated for 120 min in the presence 
of 2.8 mM D-glucose and [‘HIcholine, and then 
further incubated for 15 min at the same glucose 
concentration in the absence or presence of TPA 
(2.0pM). The lipid-bound radioactivity was in- 
creased by TPA from 371 f 24 to 478 + 
17 cpm/islet (n = 3 in each case, p < 0.025). 
3.3. Insulin output 
Phospholipase C (10 munits/ml) stimulated in- 
sulin release, whether in the absence or presence of 
D-glucose (table 2, lines 1,2). In this respect, the 
enzyme extracted from B. cereus was more potent 
than that from C. perfringens (table 4, lines 2,3). 
The absolute magnitude of the increment in the 
secretion rate was not significantly different at 3.3, 
8.3 and 16.7 mM D-glucose, respectively (table 2, 
lines 3,5,6). When the islets were incubated for 30, 
60 or 90 min at a low glucose concentration 
(3.3 mM), the phospholipase-induced increase in 
insulin output represented a fairly sustained 
phenomenon. Indeed, when expressed per min, the 
increment in the secretion rate after 90 min incuba- 
tion was not significantly lower than the initial 
value enregistered during the first 30 min of in- 
cubation (paired ratio: 79.8 -t 19.2%; n = 18). 
When the islets were incubated in the absence of 
CaClz, the phospholipase-induced increase in in- 
sulin output was not significantly different from 
that seen in the presence of CaClz (table 4, lines 
3,4). At low glucose concentration, the secretory 
response to phospholipase C extracted from B. 
cereus was of a magnitude comparable to that 
evoked by 2.0pM TPA. Thus, over 90 min in- 
cubation in the presence of 2.8 mM D-glucose, 
TPA (2.0/1M) augmented insulin output from a 
basal value of 16.6 + 1.7 to 91.8 -t 4.5 
runits/ min per islet (n = 40 in both cases). 
4. DISCUSSION 
The present results confirm the presence of pro- 
tein kinase C activity in islet homogenates and 
reveal that in islets, like in other tissues [14,15], 
TPA can substitute for diacylglycerol as an enzyme 
activator. In the presence of TPA, the K, of this 
kinase for Ca2+ was well suited to allow activation 
of the enzyme in response to physiological changes 
in cytosolic Ca2+ concentrations. 
The direct activation of protein kinase C by 
TPA may account, in part at least, for the in- 
sulinotropic action of the phorbol ester [ 16-191. 
Indeed, TPA failed to cause phosphoinositide 
breakdown in intact islets. The finding that TPA 
augmented the “P- and [3H]choline- labelling of 
phosphatidylcholine, whilst failing to affect the in- 
corporation of [3H]glycerol in this phospholipid, 
indicates that TPA specifically enhanced the label- 
ling of the polar head-group of phosphatidyl- 
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choline. A comparable effect of TPA was describ- 
ed in other cell types, e.g., in mouse ascites cells 
[20], and ascribed to stimulation of the reaction 
catalyzed by the enzyme CTP : phosphocholine 
cytidyltransferase [21]. 
The view that activation of protein kinase C may 
result in stimulation of insulin release is supported 
by the observation that phospholipase C provokes 
insulin release from intact islets [9]. In this respect, 
the reason why the enzyme extracted from B. 
cereus was more potent than that derived from C. 
perfringens is open to speculation. The present 
study reveals that exogenous phospholipase C 
stimulates insulin release both in the absence and 
presence of glucose. At glucose concentrations of 
3.3 mM or more, the absolute magnitude of the in- 
crement in insulin output attributable to 
phospholipase C was little affected by the concen- 
tration of the hexose. The stimulation of insulin 
release by phospholipase C resembled that evoked 
by TPA in being a sustained phenomenon still 
detectable in media deprived of CaC12 [171. The ef- 
fect of phospholipase C could be due, therefore, to 
liberation of diglyceride from endogenous 
phospholipids and subsequent activation of pro- 
tein kinase C. 
Taken as a whole, the present data raise the idea 
that the activation of protein kinase C may ac- 
count, in part at least, for the capacity of TPA to 
stimulate insulin release. This is not to deny that 
TPA also exerts modest but significant effects 
upon the handling of Ca2+ by the islet cells [ 17,181. 
However, the knowledge that TPA fails to affect 
45Ca net uptake by the islets [17,18] and the finding 
that the secretory response to either TPA or ex- 
ogenous phospholipase C is rather resistant to a 
shortage in extracellular Ca2+ suggest hat activa- 
tion of protein kinase C may stimulate insulin 
release even at close-to-basal cytosolic Ca2+ con- 
centrations. A similar situation was recently 
reported in human platelets [22]. 
Several insulinotropic agents, including all 
nutrient secretagogues, timulate the hydrolysis of 
phosphoinositides in the islet cells by a 
phospholipase C mechanism [11,12,23]. It is con- 
ceivable, therefore, that such a ‘phosphatidyl- 
inositol effect’ participates, via activation of pro- 
tein kinase C and, possibly, other mechanisms 
t241, in the secretory response to these 
secretagogues. It could be argued that the secretory 
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response to glucose differs from that evoked by 
TPA or exogenous phospholipase C in its greater 
sensitivity to a decrease in extracellular Ca” con- 
centration. However, the effect of glucose to 
stimulate the hydrolysis of phosphoinositides is 
itself impaired in the absence of extracellular Ca2+ 
[12,23]. 
As our knowledge on the biophysical and 
biochemical organization of the pancreatic B-cell 
progresses, it becomes ever more evident that the 
secretory response of this cell to suitable 
secretagogues involves a great number of intercon- 
nected cellular events. This work emphasizes the 
view that protein kinase C may represent an essen- 
tial component of this complex process of 
stimulus-secretion coupling. 
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